Hôpital Saint-Louis is a hospital in Paris, France. It was built in 1611 by architect Claude Vellefaux at the request of Henry IV of France.

During the past decade, Hopital Saint-Louis / Service d'Hematologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Saint-Louis / Service d'Hematologie" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Saint-Louis / Service d'Hematologie" are "Myelodysplastic Syndrome" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Anaplastic Large-Cell Lymphoma" (1 trials), "Non-Hodgkin Lymphoma" (1 trials) and "T-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Hopital Saint-Louis / Service d'Hematologie" in a lesser frequency.

Most popular intervention types in "Hopital Saint-Louis / Service d'Hematologie" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "33A" (1 trials), "Azacitidine" (1 trials), "Azacitidine and oral vorinostat" (1 trials), "azacitidine" (1 trials) and "brentuximab vedotin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Saint-Louis / Service d'Hematologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Saint-Louis / Service d'Hematologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hopital Saint-Louis / Service d'Hematologie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Saint-Louis / Service d'Hematologie, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".